Of note, the bioactivity distributions across compounds tested in each variant were highly diverse (Figure ), thus relevant in addition to the point mean differences. Together, this type of analysis pinpoints chemical patterns (as highlighted in Figure for the maximum common substructures of compounds in each cluster) driving differences in bioactivity across variants.